We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.14B
AUM Growth
-$1.26B
Cap. Flow
-$1.81B
Cap. Flow %
-19.82%
Top 10 Hldgs %
41.43%
Holding
1,256
New
311
Increased
521
Reduced
82
Closed
288
Avg Time Held Equity + Options
2.1 quarters
Top 10 Avg Time Held Equity + Options
0.3 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
2.1 quarters
Top 10 Avg Time Held Equity only
0.3 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$680M
2
CTXS
Citrix Systems Inc
CTXS
+$434M
3
ROG icon
Rogers Corp
ROG
+$386M
4
ATVI
Activision Blizzard
ATVI
+$344M
5
MIME
Mimecast Limited
MIME
+$253M

Top Sells

Rank Stock Value
1
INFO icon
IHS Markit Ltd. Common Shares
INFO
+$1.62B
2
NUAN
Nuance Communications, Inc.
NUAN
+$1.61B
3
XLNX
Xilinx Inc
XLNX
+$638M
4
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$465M
5
CONE
CyrusOne Inc Common Stock
CONE
+$464M

Sector Composition

Rank Sector Weight
1 Technology 30.21%
2 Financials 21.65%
3 Healthcare 15.19%
4 Industrials 8.94%
5 Miscellaneous 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ACAH
676
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$1.01M 0.01%
102,949
+1,814
+2% +$17.8K
2021 Q4
1 quarter
STRO icon
677
Sutro Biopharma
STRO
$176M
$986K 0.01%
+12,000
New +$1.14M
2022 Q1
0 quarters
INCY icon
678
Incyte
INCY
$22.5B
$979K 0.01%
+12,330
New +$897K
2022 Q1
0 quarters
KRC icon
679
Kilroy Realty
KRC
$3.92B
$976K 0.01%
12,773
+2,573
+25% +$181K
2020 Q4
5 quarters
CMRX icon
680
DELISTED
Chimerix, Inc.
CMRX
$962K 0.01%
+210,000
New +$1.17M
2022 Q1
0 quarters
PTGX icon
681
Protagonist Therapeutics
PTGX
$9.03B
$947K 0.01%
+40,000
New +$1.13M
2022 Q1
0 quarters
GLUE icon
682
Monte Rosa Therapeutics
GLUE
$850M
$939K 0.01%
+67,000
New +$930K
2022 Q1
0 quarters
ENDP
683
PUT
DELISTED
Endo International plc
ENDP
$927K 0.01%
447,500
-131,900
-23% -$387K
2021 Q2
3 quarters
ACRS icon
684
Aclaris Therapeutics
ACRS
$499M
$922K 0.01%
+53,502
New +$730K
2022 Q1
0 quarters
AXGN icon
685
Axogen
AXGN
$2.13B
$913K 0.01%
+115,000
New +$993K
2022 Q1
0 quarters
ONON icon
686
On Holding
ONON
$11.8B
$910K 0.01%
36,057
+4,555
+14% +$121K
2021 Q3
2 quarters
AXSM icon
687
Axsome Therapeutics
AXSM
$8.41B
$906K 0.01%
+21,900
New +$679K
2022 Q1
0 quarters
VSTM icon
688
Verastem
VSTM
$799M
$902K 0.01%
+53,333
New +$918K
2022 Q1
0 quarters
IOVA icon
689
Iovance Biotherapeutics
IOVA
$6.5B
$899K 0.01%
+54,000
New +$835K
2022 Q1
0 quarters
MRSN icon
690
DELISTED
Mersana Therapeutics
MRSN
$894K 0.01%
+8,960
New +$1.05M
2022 Q1
0 quarters
ORTX
691
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$889K 0.01%
+124,902
New +$1.22M
2022 Q1
0 quarters
SYBX icon
692
DELISTED
Synlogic
SYBX
$877K 0.01%
+24,365
New +$759K
2022 Q1
0 quarters
FORG
693
DELISTED
ForgeRock, Inc.
FORG
$877K 0.01%
40,000
-25,391
-39% -$429K
2021 Q3
2 quarters
DEI icon
694
Douglas Emmett
DEI
$1.59B
$866K 0.01%
+25,925
New +$850K
2022 Q1
0 quarters
BYND icon
695
PUT
Beyond Meat
BYND
$119M
$856K 0.01%
2,000
+333
+20% +$549K
2021 Q4
1 quarter
AUTL icon
696
Autolus Therapeutics
AUTL
$442M
$834K 0.01%
+200,000
New +$841K
2022 Q1
0 quarters
ZNTL icon
697
Zentalis Pharmaceuticals
ZNTL
$226M
$808K 0.01%
+17,502
New +$944K
2022 Q1
0 quarters
LEAP.U
698
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$805K 0.01%
+80,892
New +$810K
2022 Q1
0 quarters
ADT icon
699
ADT
ADT
$4.79B
$750K 0.01%
98,872
+12,596
+15% +$95.8K
2018 Q2
15 quarters
RIGL icon
700
Rigel Pharmaceuticals
RIGL
$893M
$748K 0.01%
+25,000
New +$677K
2022 Q1
0 quarters
26 27
28
29 30

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2022 Portfolio in Review

As of Q1 2022, UBS O'Connor held 1,256 positions worth $9.14B, down 12% from $10.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.81B in Q1 2022, closing 288 positions and reducing 82 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $1.62B position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Citrix Systems Inc worth $433M.

  • UBS O'Connor's largest Q1 2022 buy was Citrix Systems Inc: 4,293,687 shares worth $433M.
  • UBS O'Connor added most to Cerner Corp in Q1 2022, an estimated $680M increase.
  • UBS O'Connor's biggest Q1 2022 reduction was EQT Corp, cutting an estimated $81.9M.
  • UBS O'Connor fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $1.62B.
  • UBS O'Connor's ten largest holdings make up 41% of its $9.14B portfolio in Q1 2022.
  • UBS O'Connor opened 311 new positions and closed 288 in Q1 2022.
  • UBS O'Connor's portfolio value fell 12% quarter-over-quarter to $9.14B.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.